Categories AlphaGraphs, Earnings, Health Care
Infographic: Highlights of Merck & Co. (MRK) Q3 2020 earnings report
Merck & Co., Inc. (NYSE: MRK) reported stronger than expected earnings and sales for the third quarter of 2020. The company’s stock gained early Tuesday immediately after the announcement.

Worldwide sales edged up 1% year-over-year to $12.55 billion and far exceeded expectations. Excluding foreign exchange impacts, sales grew 2%. The top-line benefitted from strength in the oncology and human health vaccines.
Net earnings, on an adjusted basis, rose to $1.74 per share from $1.51 per share in the third quarter of 2019 and surpassed the market’s forecast.
Unadjusted net income advanced to $2.94 billion or $1.16 per share from $1.90 billion or $0.74 per share last year.
Read management/analysts’ comments on Merck’s Q3 2020 earnings
Shares of the company gained during Tuesday’s premarket trading, after closing the previous session lower.
Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!
Most Popular
V Earnings: Key quarterly highlights from Visa’s Q1 2023 financial results
Visa Inc. (NYSE: V) reported first quarter 2023 earnings results today. Net revenues grew 12% year-over-year to $7.9 billion. GAAP net income rose 6% to $4.2 billion while EPS grew
Earnings: Highlights of Intel’s (INTC) Q4 2022 financial results
Intel Corporation (NASDAQ: INTC) Thursday reported a decline in adjusted earnings and revenues for the fourth quarter. The semiconductor giant also provided guidance for the first quarter of 2023. Fourth-quarter
McCormick (MKC) expects to drive sales growth in 2023 through pricing actions and cost savings
Shares of McCormick & Company Inc. (NYSE: MKC) were down over 5% on Thursday after the company missed expectations on its fourth quarter 2022 results and provided a lower-than-expected earnings